isoxsuprine

Clinical effect not specified

Source: DDInter

Increased risk of hypotension, orthostatic hypotension, dizziness, and syncope.

Monitor blood pressure closely, especially during initiation or dose adjustments of either drug. Consider reducing the dose of antihypertensive agents if symptomatic hypotension occurs. Advise patients to rise slowly from a sitting or lying position.

Reduced efficacy of isoxsuprine (e.g., for tocolysis or peripheral vasodilation). Beta-blockers may also mask the signs of isoxsuprine-induced tachycardia.

Monitor for reduced therapeutic effect of isoxsuprine. If used for tocolysis, consider alternative agents or increased monitoring for uterine contractions. Be aware that beta-blockers can mask tachycardia, a common side effect of isoxsuprine.

Increased risk of tachycardia, palpitations, hypertension, and other cardiovascular adverse effects.

Avoid concomitant use due to the increased risk of cardiovascular stimulation. If co-administration is unavoidable, monitor cardiovascular parameters closely.

Increased risk of hypotension during surgery. Isoxsuprine's beta-adrenergic effects might interact with anesthetic agents, potentially leading to arrhythmias.

Inform the anesthesiologist about isoxsuprine use. Monitor blood pressure and cardiac rhythm closely during surgery. Be prepared to manage hypotension.

Increased risk of hypertension, tachycardia, and other cardiovascular adverse effects.

Use with caution. Monitor blood pressure and heart rate closely. Consider alternative treatments if possible. If co-administration is necessary, start with low doses and titrate carefully.

Potentiated hypotensive effects, leading to increased risk of dizziness, syncope, and falls.

Avoid concomitant use if possible. If co-administration is necessary, monitor blood pressure frequently and advise patients about the signs and symptoms of hypotension. Adjust doses as needed.

Significant potentiation of hypotensive effects, leading to severe hypotension, syncope, and potentially cardiovascular collapse.

Avoid concomitant use due to the high risk of severe hypotension. If a patient is on isoxsuprine, PDE5 inhibitors should be used with extreme caution or avoided.

Increased risk of cardiovascular adverse effects (e.g., tachycardia, arrhythmias, angina) when isoxsuprine is used in patients with hyperthyroidism or those on thyroid hormone replacement.

Use with caution, especially in patients with pre-existing cardiac conditions. Monitor heart rate and rhythm. Consider lower doses of isoxsuprine.

Increased risk of orthostatic hypotension, dizziness, and syncope. TCAs may also potentiate the cardiac stimulant effects of isoxsuprine.

Monitor blood pressure and heart rate closely. Advise patients about orthostatic hypotension. Consider lower starting doses of either drug and titrate carefully.